2011 Oxidative Stress and Disease Gordon Research Conference

2011 氧化应激与疾病戈登研究会议

基本信息

  • 批准号:
    8045654
  • 负责人:
  • 金额:
    $ 5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-09-30 至 2011-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The Gordon Research Conference (GRC) on Oxidative Stress and Disease is designed to provide scientists from a wide range of disciplines with the latest research findings on the role of oxidative stress in a variety of disease processes with emphasis on shared mechanisms. This research conference has been held every 2 years since 1999; it is part of over 150 conferences that will be organized in 2011 by the GRC, an organization internationally known for the high- quality, cutting edge nature of its meetings. Although a comparatively young GRC conference, attendance at the meeting has grown steadily since its inception over ten years ago. The 2011 GRC on Oxidative Stress and Disease will be held March 14-18, 2011 at the Sheraton Four Point/Holiday Inn Express in Ventura, CA. The program for the meeting described in this application has been assembled around the theme of "Emerging research areas in the study of oxidative stress and disease" which have recently collectively changed the way in which we think about the impact of oxidative stress on cellular mechanisms involved in human disease. These will include the impact of oxidative stress on, for example, epigenetics, microRNAs, stem cells, and mitochondrial dynamics. Findings associated with these novel areas of research are in turn likely to affect the manner in which basic research is translated into interventions for oxidative stress-related disorders. This Gordon Research Conference will bring together leading international experts with a broad range of interests related to diverse aspects of oxidative stress and disease and will create a high quality scientific forum for discussion of the latest findings on basic mechanisms and their translational implementation into interventions aimed at novel disease therapies. In addition, for the first time in the history of this conference, a pre-conference Gordon-Kenan Research Seminar will be organized by junior investigators at the postdoctoral level. Activities during the Seminar will be oriented to junior investigators and are intended to: (1) provide them with the basic background on common mechanisms involved in oxidative stress and disease necessary to maximize their understanding of the science which will be discussed in the subsequent conference, (2) receive feedback on their ongoing research projects from experts in the field, and (3) facilitate their interaction with senior members of this scientific community to promote networking between junior and more senior researchers in the field. We fully anticipate that the scientific discussions, research talks, poster sessions, and other informal interactions between the participants of this conference will contribute to advancing our understanding of novel molecular mechanisms involved in oxidative stress- related human disease and will set the basis for the development of collaborative interventions aimed at promoting new therapeutic treatments for these disorders. PUBLIC HEALTH RELEVANCE: The Gordon Research Conference on Oxidative Stress and Disease together with the pre- meeting Gordon Kenan Research Seminar will bring together leaders in a variety of scientific disciplines relevant to the study of oxidative stress-related disorders and junior investigators constituting the future generation of researchers in this field. The scientific presentations, discussions and workshops during this conference are designed to expand our understanding of the mechanisms by which oxidative stress may contribute to disease processes. It is anticipated that the collegial and cooperative atmosphere that has traditionally characterized this conference will provide the perfect setting for the intellectual development and implementation of novel therapeutics for this set of related diseases.
描述(由申请人提供):戈登研究会议(GRC)的氧化应激和疾病的目的是提供科学家从广泛的学科与氧化应激在各种疾病过程中的作用的最新研究成果,重点是共享机制。该研究会议自1999年以来每两年举行一次;它是GRC将于2011年组织的150多个会议的一部分,GRC是一个以其会议的高质量,前沿性而闻名的国际组织。虽然是一个相对年轻的GRC会议,但自十多年前成立以来,出席会议的人数稳步增长。2011年关于氧化应激和疾病的GRC将于2011年3月14日至18日在加利福尼亚州文图拉的喜来登四点/假日快捷酒店举行。本申请中描述的会议计划已围绕“氧化应激和疾病研究中的新兴研究领域”的主题进行了组装,这些研究领域最近共同改变了我们思考氧化应激对人类疾病中涉及的细胞机制的影响的方式。这些将包括氧化应激对例如表观遗传学、microRNA、干细胞和线粒体动力学的影响。与这些新的研究领域相关的发现反过来可能会影响基础研究转化为氧化应激相关疾病干预措施的方式。本次戈登研究会议将汇集与氧化应激和疾病的各个方面相关的广泛兴趣的国际领先专家,并将创建一个高质量的科学论坛,讨论基本机制的最新发现及其转化实施为旨在治疗新疾病的干预措施。此外,在本次会议的历史上第一次,会前戈登凯南研究研讨会将由博士后水平的初级研究人员组织。研讨会期间的活动将面向初级调查员,目的是:(1)为他们提供有关氧化应激和疾病的共同机制的基本背景,以最大限度地提高他们对将在随后的会议上讨论的科学的理解,(2)从该领域的专家那里获得关于他们正在进行的研究项目的反馈,以及(3)促进他们与该科学界高级成员的互动,以促进该领域初级和高级研究人员之间的网络联系。我们完全期待本次会议参与者之间的科学讨论,研究会谈,海报会议和其他非正式互动将有助于促进我们对氧化应激相关人类疾病所涉及的新分子机制的理解,并将为开发旨在促进这些疾病新治疗方法的合作干预奠定基础。 公共卫生相关性:戈登氧化应激和疾病研究会议以及会前戈登凯南研究研讨会将汇集与氧化应激相关疾病研究相关的各种科学学科的领导者和构成该领域未来一代研究人员的初级研究人员。本次会议期间的科学报告,讨论和研讨会旨在扩大我们对氧化应激可能导致疾病过程的机制的理解。预计本次会议传统上特有的合议和合作气氛将为这组相关疾病的新型疗法的智力开发和实施提供完美的环境。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Julie Kay Andersen其他文献

Julie Kay Andersen的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Julie Kay Andersen', 18)}}的其他基金

Novel mitochondria-to-lysosome crosstalk contributes to lysosomal dysfunction during aging
新型线粒体与溶酶体串扰导致衰老过程中溶酶体功能障碍
  • 批准号:
    10723050
  • 财政年份:
    2023
  • 资助金额:
    $ 5万
  • 项目类别:
Neuronal FXR as a potential therapeutic target for Alzheimer's disease
神经元 FXR 作为阿尔茨海默病的潜在治疗靶点
  • 批准号:
    10374862
  • 财政年份:
    2020
  • 资助金额:
    $ 5万
  • 项目类别:
Cellular senescence and Alzheimer's disease
细胞衰老和阿尔茨海默病
  • 批准号:
    10044328
  • 财政年份:
    2020
  • 资助金额:
    $ 5万
  • 项目类别:
Neuronal FXR as a potential therapeutic target for Alzheimer's disease
神经元 FXR 作为阿尔茨海默病的潜在治疗靶点
  • 批准号:
    10600989
  • 财政年份:
    2020
  • 资助金额:
    $ 5万
  • 项目类别:
Research Development Core
研究开发核心
  • 批准号:
    10649616
  • 财政年份:
    2020
  • 资助金额:
    $ 5万
  • 项目类别:
New mechanistic insights into how the gut metabolite urolithin A extends lifespan and prevents AD
关于肠道代谢物尿石素 A 如何延长寿命和预防 AD 的新机制见解
  • 批准号:
    10614896
  • 财政年份:
    2018
  • 资助金额:
    $ 5万
  • 项目类别:
Environmental exposure and astrocytic senescence: novel link to PD?
环境暴露和星形细胞衰老:与 PD 的新联系?
  • 批准号:
    8758627
  • 财政年份:
    2014
  • 资助金额:
    $ 5万
  • 项目类别:
2011 Oxidative Stress and Disease Gordon Research Conference
2011 氧化应激与疾病戈登研究会议
  • 批准号:
    8209520
  • 财政年份:
    2010
  • 资助金额:
    $ 5万
  • 项目类别:
2011 Oxidative Stress and Disease Gordon Research Conference
2011 氧化应激与疾病戈登研究会议
  • 批准号:
    8214198
  • 财政年份:
    2010
  • 资助金额:
    $ 5万
  • 项目类别:
Pharmacology of Lifespan Extension
延长寿命的药理学
  • 批准号:
    9521330
  • 财政年份:
    2008
  • 资助金额:
    $ 5万
  • 项目类别:

相似海外基金

A novel treatment for REBOA complications: Hydrogen gas inhalation therapy to alleviate oxidative stress due to ischemia-reperfusion injury
REBOA并发症的新型治疗方法:氢气吸入疗法减轻缺血再灌注损伤引起的氧化应激
  • 批准号:
    23K21458
  • 财政年份:
    2024
  • 资助金额:
    $ 5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Oxidative Stress and Mitochondrial Dysfunction in Chemogenetic Heart Failure
化学遗传性心力衰竭中的氧化应激和线粒体功能障碍
  • 批准号:
    10643012
  • 财政年份:
    2023
  • 资助金额:
    $ 5万
  • 项目类别:
LRRK2 and oxidative stress in Parkinson’s disease
LRRK2 与帕金森病的氧化应激
  • 批准号:
    10799999
  • 财政年份:
    2023
  • 资助金额:
    $ 5万
  • 项目类别:
Developing trimester-specific placenta organ-on-chips to model healthy and oxidative stress and inflammation-associated pathologies
开发妊娠期特异性胎盘器官芯片来模拟健康和氧化应激以及炎症相关的病理学
  • 批准号:
    10732666
  • 财政年份:
    2023
  • 资助金额:
    $ 5万
  • 项目类别:
IntBIO: Collaborative Research: Integrating nanobiotechnologies to understand the role of nitro-oxidative stress in the coral-dinoflagellate mutualistic symbiosis dynamics
IntBIO:合作研究:整合纳米生物技术来了解硝基氧化应激在珊瑚-甲藻互利共生动态中的作用
  • 批准号:
    2316389
  • 财政年份:
    2023
  • 资助金额:
    $ 5万
  • 项目类别:
    Standard Grant
Investigation of the effects of macrolide antimicrobial agents on oxidative stress tolerance in trophoblast cells
大环内酯类抗菌药物对滋养层细胞氧化应激耐受性影响的研究
  • 批准号:
    23K08863
  • 财政年份:
    2023
  • 资助金额:
    $ 5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Determining the role of Rac1 palmitoylation in cardiac hypertrophy and oxidative stress
确定 Rac1 棕榈酰化在心脏肥大和氧化应激中的作用
  • 批准号:
    10534386
  • 财政年份:
    2023
  • 资助金额:
    $ 5万
  • 项目类别:
Placental identified NHIP regulating neuronal oxidative stress in autism
胎盘发现 NHIP 调节自闭症神经元氧化应激
  • 批准号:
    10717990
  • 财政年份:
    2023
  • 资助金额:
    $ 5万
  • 项目类别:
The role of oxidative stress in reduced microvascular function after gestational diabetes
氧化应激在妊娠糖尿病后微血管功能下降中的作用
  • 批准号:
    10712433
  • 财政年份:
    2023
  • 资助金额:
    $ 5万
  • 项目类别:
Structural systems biology of microenvironmental oxidative stress and synthetic biology intervention
微环境氧化应激的结构系统生物学与合成生物学干预
  • 批准号:
    10715112
  • 财政年份:
    2023
  • 资助金额:
    $ 5万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了